MedPath

Reduction of Abdominal Obesity and Insulin Resistance in Women

Not Applicable
Completed
Conditions
Obesity
Registration Number
NCT00664495
Lead Sponsor
Queen's University
Brief Summary

The purpose of the study was to assess the effects of equivalent diet- or exercise-induced weight loss and related insulin resistance in abdominally obese women.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Premenopausal women
Exclusion Criteria
  • Smokers and diabetics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Abdominal Obesity4 months
Insulin Resistance4 Months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Queen's University

🇨🇦

Kingston, Ontario, Canada

Queen's University
🇨🇦Kingston, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.